Table 1.
Symptoms Scores, Penile Hemodynamics Parameters, and Serum Hormone Values of the Patients Before and After the Therapy.
| Before therapy | After therapy | p value | |
|---|---|---|---|
| AMS-SF (psychologic subgroup) | 17.31 ± 2.28 | 7.94 ± 1.80 | <.001 |
| AMS-SF (somatic subgroup) | 24.88 ± 5.41 | 10.31 ± 3.02 | <.001 |
| AMS-SF (sexual subgroup) | 18.25 ± 3.96 | 7.47 ± 2.09 | <.001 |
| Total AMS-SF score | 59. 50 ± 10.40 | 25.84 ± 6.02 | <.001 |
| Total IIEF-5 score | 11.03 ± 4.04 | 18.03 ± 6.87 | <.001 |
| PSV (cm/s) | 48.81 ± 12.47 | 53.19 ± 19.65 | .017 |
| EDV (cm/s) | 11.06 ± 3.66 | 5.44 ± 4.04 | <.001 |
| RI | 0.77 ± 0.06 | 0.87 ± 0.12 | <.001 |
| Serum FSH level (mIU/mL) | 7.32 ± 4.07 | 6.88 ± 3.34 | .205 |
| Serum LH level (mIU/mL) | 8.39 ± 3.42 | 3.81 ± 1.66 | <.001 |
| Serum testosterone level (ng/dL) | 181.06 ± 39.84 | 509.00 ± 105.57 | <.001 |
Note. AMS-SF = sexual functions; EDV = end diastolic velocity; FSH = follicle-stimulating hormone; IIEF-5 =5-item version of the international index of erectile function; LH = luteinizing hormone; PSV = peak systolic velocity; RI = resistive index.